Peptide & Hormone Therapies for Health, Performance & Longevity | Dr. Craig Koniver

Overview

Andrew Huberman speaks with Dr. Craig Conover about peptide biology and “performance medicine,” focusing on how peptides, NAD, methylene blue, selected supplements, and hormone-related therapies are being used clinically for physical health, mental health, recovery, sleep, and longevity.

The episode repeatedly contrasts clinical observation with formal approval pathways. Conover emphasizes that many peptide uses are based on physician-supervised experience rather than large human trials, and both speakers stress sourcing, dosing, and medical oversight as central safety issues.

Major themes include GLP-1 microdosing, BPC-157 and its alternatives, growth hormone secretagogues, pinealin plus glycine for REM sleep, NAD infusions, mitochondrial support, regulatory restrictions, and the role of mindset and trust in medical care.

分段落总结

[00:00] Episode Framing and Peptide Basics

[事实] Huberman introduces Dr. Craig Conover as a physician focused on performance medicine using peptides and other therapies for mental health, physical health, and performance.
[事实] Peptides are described as small chains of amino acids, with insulin given as a familiar example.
[事实] The episode covers GLP-1 drugs, BPC-157, growth hormone secretagogues, sleep-related peptides, testosterone therapies, NAD, and selected supplements.
[事实] Huberman notes that peptide therapies may sit between lifestyle/supplements and stronger hormone therapies, but still carry safety and sourcing concerns.

[09:00] What Peptides Are and Why GLP-1s Matter

[事实] Conover defines peptides as chains of amino acids, generally 40 amino acids or fewer, while proteins are described as longer chains.
[事实] He says the body makes a very large number of peptides, while therapeutic use involves a much smaller subset.
[事实] GLP-1 agonists such as semaglutide and tirzepatide are used as an entry point because many listeners have heard of Ozempic and Mounjaro.

[10:00] GLP-1 Drugs, Weight Loss, and Motivation

[事实] Conover says semaglutide was first approved for type 2 diabetes and glucose control, with weight loss observed as a major effect.
[事实] He states that many medicines in the United States are prescribed off-label once approved for some use.
[事实] Conover says GLP-1s can help some people lose weight first, which may then motivate exercise, better eating, and broader health engagement.
[推测] The discussion frames GLP-1s not as a replacement for lifestyle change, but as a possible catalyst for people who have been unable to get traction through lifestyle alone.

[15:00] GLP-1 Microdosing, Muscle Loss, and Inflammation

[事实] Conover argues that conventional GLP-1 doses can cause weight loss too quickly, increasing concern about lean mass loss.
[事实] His clinic uses compounded lower-dose semaglutide or tirzepatide and tries to keep weight loss at about two pounds per week or less.
[事实] He encourages adequate protein intake and resistance training to help preserve muscle.
[事实] He reports seeing improvements in inflammatory markers and autoimmune-related symptoms in some patients, including a Hashimoto’s thyroiditis example.
[推测] The mechanism behind inflammation improvement is left unresolved and may involve direct immune effects, fat loss, improved mood, or multiple pathways.

[19:06] BPC-157 for Inflammation and Tissue Repair

[事实] BPC-157 is introduced as Body Protection Compound-157, with Huberman noting animal data and limited human clinical studies.
[事实] Conover describes BPC-157 as one of the most used peptides in his practice and says he has used it broadly for inflammation, soreness, joint issues, post-viral problems, and recovery.
[事实] He says his clinic moved from about 500 micrograms daily up to 5,000 micrograms daily in some protocols, often five days on and two days off.
[事实] BPC-157 is said to work systemically when injected subcutaneously, rather than needing to be injected near an injury site.

[22:46] BPC-157, Growth Hormone Receptors, and Delivery Routes

[事实] Huberman says BPC-157 may upregulate growth hormone receptors.
[事实] Conover says BPC-157 can pair with growth hormone-releasing peptides because it may make growth hormone signaling more efficient.
[事实] Oral BPC-157 is described as more gut-targeted, while Conover reports stronger clinical results from injections even for gastrointestinal issues.
[事实] Conover says BPC-157 seems especially useful around ligaments and tendons and has been combined with PRP or PRF in clinical settings.

[29:51] Testosterone, Nandrolone, and Fertility Risks

[事实] The discussion shifts from black-market compounds to legally prescribed anabolic agents such as testosterone cypionate, testosterone enanthate, and nandrolone.
[事实] Conover says nandrolone can be combined with testosterone and may help some older patients with joint or bone-related issues.
[事实] Huberman warns that younger men often look to synthetic testosterone unnecessarily when sleep, nutrition, and recovery may be more appropriate first-line targets.
[事实] Conover describes a young patient who had used testosterone and growth hormone for years and later had zero sperm when trying to have children.
[推测] The segment positions physician oversight as especially important for hormone use because the long-term tradeoffs can be substantial.

[35:00] Gray-Market Peptides and Compounding Pharmacy Safety

[事实] Huberman raises concerns about research-use peptides sold online with uncertain potency, purity, or endotoxin contamination.
[事实] Conover says some people have had serious reactions to research-type peptides not intended for human consumption.
[事实] He explains that compounding pharmacies are regulated, inspected, and required to test sterile compounds for purity and endotoxins.
[事实] Conover argues that compounding pharmacies allow individualized dosing and synergistic combinations, such as tirzepatide with sermorelin.

[40:00] Medical Oversight and BPC Alternatives

[事实] Conover says patients should be assessed for fit, contraindications, medications, conditions, and individualized dosing before peptide use.
[事实] Huberman warns that peptides labeled “not for human or animal use” may not have endotoxins removed.
[事实] Conover introduces pentadeca arginate, described as structurally similar to BPC-157 with one amino acid-related substitution.
[事实] He reports using 500 micrograms injected daily, typically Monday through Friday, as a conservative starting point.

[46:57] Peptides Versus Direct Hormone Manipulation

[事实] Conover says he generally prefers using peptides to influence hormonal pathways rather than directly manipulating hormones when possible.
[事实] He criticizes pellet-style hormone therapy because it can expose people to hormone concentrations he says would not occur naturally.
[事实] Growth hormone-releasing peptides are described as stimulating the body’s own pituitary-driven growth hormone release rather than supplying growth hormone directly.
[推测] The clinical rationale is to nudge existing biological pathways while reducing the risk of shutting down endogenous production.

[50:55] Growth Hormone Secretagogues and Their “Flavors”

[事实] Huberman reports that sermorelin improved his early-night sleep but reduced REM sleep later in the night and raised his prostate-specific antigen, which reversed after stopping.
[事实] Conover says responses vary and describes ipamorelin as relatively clean and specific, usually used at 100 micrograms or less before sleep.
[事实] GHRP-6 is described as more appetite-stimulating and potentially useful for people trying to gain size and strength.
[事实] Tesamorelin and sermorelin are described as acting through growth hormone-releasing hormone pathways, with tesamorelin noted for visceral fat reduction.

[55:35] Peptide Stacking and Dosing Breaks

[事实] Tesamorelin is described as FDA-approved for visceral fat issues in HIV-related lipodystrophy.
[事实] Conover says growth hormone-related peptides may support sleep, skin tone, recovery, resilience, and durability.
[事实] He describes earlier stacks combining BPC-157, ipamorelin, and tesamorelin for fat loss, lean mass, sleep, skin, and durability.
[事实] His preferred schedule often uses five days on and two days off, partly modeled on growth hormone dosing and partly to preserve responsiveness.

[62:03] CoQ10 and Mitochondrial Support

[事实] Conover says he is not a huge fan of excessive supplement use but does take CoQ10, specifically mentioning 200 milligrams per day in the morning.
[事实] He explains mitochondrial ATP production through glycolysis, the Krebs cycle, NADH, and the electron transport chain.
[事实] He maps different nutrients to different cytochrome points, including NAD, riboflavin, succinic acid, CoQ10, vitamin K2, methylene blue, magnesium, vitamin A, and copper.
[事实] CoQ10 is discussed as support for cytochrome three, and Conover says it has been studied as safe at much higher doses.

[65:00] Off-Label Medicine and Clinical Observation

[事实] Huberman highlights Conover’s statement that many prescriptions are used off-label.
[事实] Conover gives examples such as antibiotics, GLP-1s, and repurposed drugs in cancer-related settings.
[事实] Conover says his practice evolved from conventional family medicine toward nutritional IVs and helping patients feel better first.
[推测] This segment reinforces a central tension in the episode: formal evidence, physician experience, and patient outcomes do not always move at the same speed.

[75:00] Health Agency, Trust, and Avoiding Protocol Overload

[事实] Huberman and Conover discuss how wealth and status conversations increasingly focus on health, vitality, and longevity.
[事实] Conover warns that social media can make health feel like endless stacking of workouts, sauna, cold plunges, and diet rules.
[事实] He emphasizes surrendering to trusted guidance rather than trying to personally quarterback every intervention.
[事实] Huberman agrees that sleep, exercise, nutrition, and social connection are foundational, while tools such as peptides can potentially augment good behaviors.

[77:44] MK-677 and Hexarelin

[事实] MK-677 is described as similar to GHRP-6 but orally absorbed, and Conover says it can strongly stimulate appetite.
[事实] Conover gives an example of an older male patient who could not gain muscle and might benefit from appetite stimulation.
[事实] Hexarelin is described as an energy- and endurance-oriented growth hormone-releasing peptide that Conover prefers in the morning.
[事实] Conover gives 100 micrograms as a typical dose for hexarelin, while tesamorelin is described as 2 milligrams per dose and sermorelin as having a broad dosing range.

[81:51] Methylated B Vitamins and Homocysteine

[事实] Conover explains MTHFR as a single nucleotide polymorphism that can affect metabolic flow.
[事实] Homocysteine is described as a lab marker associated with cardiovascular risk when elevated.
[事实] Conover says methylated B vitamins and methyl donors such as methyl B12, methylfolate, methylated B6, trimethylglycine, and methionine can help lower homocysteine.
[事实] He prefers these in the morning, but says some people may try them during an afternoon slump.

[85:08] Pinealin, Glycine, and REM Sleep

[事实] Huberman says injectable pinealin combined with glycine doubled his REM sleep in his own tracking experience.
[事实] Conover says pinealin is one of the smallest peptides and may act through pinealocytes and the pineal gland.
[事实] Epitalon is mentioned as a Russian peptide formerly combined with pinealin and associated with circadian rhythm and DNA repair discussions.
[事实] Conover reports not seeing negative side effects from pinealin in his clinical experience.
[推测] The proposed mechanism involving pineal regeneration and melatonin production is explicitly speculative in the conversation.

[91:04] Glycine, Liver Detoxification, and Toxic Exposures

[事实] Conover likes glycine as an inhibitory neurotransmitter that can calm the nervous system before sleep.
[事实] He commonly starts oral glycine at 3 to 5 grams before bed and may increase it if no effect is noticed.
[事实] Glycine is also discussed as supporting phase two liver detoxification through amino acid conjugation.
[事实] Conover mentions polyphenols, matcha, glutathione, and glycine as ways to support phase two liver activity.

[99:03] Stem Cells, Thymosin Alpha-1, and Cerebrolysin

[事实] Conover says autologous cell therapies such as PRP are allowed when cells are taken from a person and returned within the FDA’s outlined time window.
[事实] Both speakers discuss risks from overly aggressive stem cell applications, including eye injections and disc injections.
[事实] Thymosin alpha-1 is described by Conover as previously useful for immune modulation, autoimmune conditions, post-COVID issues, and long COVID.
[事实] Cerebrolysin is described as available and used for brain-related recovery contexts, but Conover says some patients experience a dark mood shift for a day or two.

[104:28] Methylene Blue for Mitochondria and Cognition

[事实] Methylene blue is introduced as a compound that has become more common despite seeming unconventional.
[事实] Conover says it binds cytochrome C oxidase, is used in carbon monoxide poisoning, and can help red blood cells carry oxygen.
[事实] He says oral methylene blue is well absorbed and commonly uses no more than 10 milligrams in the morning.
[事实] It may turn urine green or blue, and liquid forms can temporarily turn the mouth blue.
[事实] Conover describes it as a cognitive stimulant, a mild MAOI, and possibly antiviral through mitochondrial effects.

[111:13] NAD Infusions and Clinical Effects

[事实] Huberman describes an anecdote in which a 750 milligram NAD infusion during COVID coincided with rapid symptom improvement and a negative test the next day.
[事实] Conover says his clinic helped settle on 750 milligrams intravenously as a practical dose after experimenting with different amounts.
[事实] He describes NAD as transformational in some patients, including one with chronic Epstein-Barr virus-related fatigue and depression.
[事实] Reported effects include improved creativity, mood, energy, sleep efficiency, language, and brain clarity.

[119:00] NAD Protocols, Cost, and Alternatives

[事实] Conover says older NAD addiction protocols used 3,000 milligrams over many hours for 10 straight days.
[事实] His clinic uses a loading approach of five treatments in 10 days, followed by maintenance that is often monthly.
[事实] He also uses subcutaneous NAD at around 100 milligrams, five days on and two days off, though it can cause stomach cramping.
[事实] For lower-cost options, he ranks IV NAD first, subcutaneous NAD next, then oral precursors such as NMN or NR, with a preference for NMN over NR.

[127:07] PT-141 and Melanocortin Pathways

[事实] PT-141 is discussed as a peptide related to melanocyte-stimulating hormone pathways and approved under the brand name Vyleesi for female hypoactive sexual desire.
[事实] Conover says it can also be used in men and may act through a neurogenic erectile dysfunction mechanism rather than only blood flow.
[事实] Melanotan is discussed as affecting melanocytes and producing a tanning effect that some people find unnatural.
[事实] Conover says PT-141 has a narrow therapeutic window and too much can cause nausea.

[130:00] FDA Restrictions, Pharma Incentives, and Safety

[事实] Huberman asks whether FDA peptide restrictions reflect safety concerns, pharmaceutical incentives, or both.
[事实] Conover says he thinks it is probably both: genuine safety oversight plus overreach and commercial incentives.
[事实] They discuss peptides such as MK-677, thymosin alpha-1, BPC-157, and CJC-1295 as examples affected by regulatory changes during the conversation.
[事实] Conover argues that people must operate within legal boundaries while also becoming informed advocates for their own health.

[135:00] Limits of Conventional Medicine

[事实] Conover says modern medicine is excellent for life-and-death situations and describes a blood clot near his liver where pharmaceuticals helped save his life.
[事实] He argues that chronic disease, food quality, toxic exposures, and overreliance on pills are not being addressed well enough.
[事实] He criticizes a conventional medical model dominated by prescriptions and underemphasizing nutrition, movement, and other modalities.
[推测] His position is not anti-drug, but anti-reductionist: pharmaceuticals have value, yet cannot by themselves define health.

[140:00] Positive Thought, Purpose, and the Human Side of Care

[事实] Huberman asks Conover about mindset and health, including stress, immune function, and positive thoughts.
[事实] Conover says he believes positive framing is one of the most profound ways to affect life, while acknowledging that suffering is real and not everyone has the same difficulty level.
[事实] Conover says he stopped taking insurance in 2010 because short visits and prescription writing did not align with the kind of care he wanted to provide.
[事实] He describes peptides and NAD as gateways for building trust so he can help patients with energy, positivity, and purpose.

[145:00] Closing and Resources

[事实] Huberman thanks Conover for discussing peptides, compounds, regulatory bodies, medicine, and the human component of care.
[事实] Conover thanks Huberman and says many patients bring Huberman Lab topics to him for discussion.
[事实] The episode closes with references to show notes, a previous peptide solo episode, podcast subscriptions, Huberman’s book, social media, and the newsletter.

播客点评/总结

This episode is valuable because it maps a fast-moving and confusing area of health practice through a clinician’s lens. It clearly distinguishes peptide categories, discusses specific dosing patterns used in Conover’s practice, and repeatedly returns to sourcing, purity, medical supervision, and regulatory ambiguity.

Its strongest sections are the practical comparisons: GLP-1 microdosing versus standard dosing, BPC-157 versus pentadeca arginate, different growth hormone secretagogues by effect profile, and NAD infusion versus subcutaneous or oral precursor options. The sleep discussion around pinealin and glycine is especially striking, but much of it is based on personal and clinical observation rather than large human trials.

The main limitation is evidence quality. The transcript contains many clinical anecdotes and mechanistic explanations, but several claims are explicitly experiential, speculative, or not yet backed by robust human clinical data. Listeners should treat the episode as a map of emerging clinical practice, not as a self-prescription guide.

[推测] This episode is best suited for listeners already interested in longevity medicine, peptide therapy, recovery, sleep optimization, mitochondrial health, or regulatory questions around emerging therapeutics. It is less suitable for people looking for simple, conservative, guideline-based medical advice without experimental or off-label discussion.